Clinical Trial Update: Ketamine for Treatment-Resistant Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ketamine for treatment-resistant bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Joshua Rosenblat | Conditions: Bipolar Disorder, Bipolar Depression | Phase 2 | Status: COMPLETED